Astellas reports 1-year safety data of fezolinetant to treat menopause symptoms
JHVEPhoto/iStock Editorial via Getty Images Astellas Pharma (OTCPK:ALPMF) (OTCPK:ALPMY) reported data from a phase 3 trial ...
Read more
Tag: fezolinetant
Astellas fezolinetant to treat menopause symptoms gets FDA review
Grandbrothers The U.S. Food and Drug Administration (FDA) accepted to review Astellas Pharma's (OTCPK:ALPMF) (OTCPK:ALPMY) application ...
Read more
Copyright © 2022 - The Optic News.
The Optic News is not responsible for the content of external sites.